Home Therapy With VPRIV in Gaucher's Disease

Inclusion Criteria: * Male or female patients with a confirmed diagnosis of Gaucher disease type 1 * Age\> 2 years * patients who have at least 3 infusions (6 weeks) at least 5-year or 5-6 infusions (10-12 weeks) at 2 - to 4-year patients have received VPRIV ® and tolerate well * The patient is compliant, the previous VPRIV ® infusions were / performed approximately every 2 weeks in the center during office visits * The patient was already before inclusion in this study for a home infusion therapy and has consented to (or their legal representative) * The patient / be lawful. Representative has consented in writing to participate in this study. Exclusion criteria: • The patient is participating in a clinical trial with a medicinal product